Using nano “couriers” to deliver PKD drugs to just the right address
The term “mRNA lipid nanoparticle” has become common of late, given the use of Pfizer/BioNTech’s and Moderna’s COVID-19 vaccines make of nanoparticles to carry mRNA into cells. Once inside a cell, the mRNA instructs the cell to make pieces of the proteins that make up the SARS-CoV-2 virus, a process called “translation.” In so doing, our cells trigger an immune response, developing antibodies that will enable the immune system to …
